SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Clinical trials for SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN) explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN) trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Glow-in-the-Dark dye could help surgeons spot hidden cancer cells
Diagnosis Not yet recruitingThis early-stage trial tests whether a fluorescent dye attached to an immunotherapy drug can help surgeons see head and neck cancer cells during surgery. About 40 adults with head and neck cancer will receive the dye before their standard surgery. The main goal is to check if the…
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated May 22, 2026 14:02 UTC
-
New study aims to predict who will respond to chemoradiation for head and neck cancer
Knowledge-focused Not yet recruitingThis study will test whether combining imaging scans (CT, MRI, PET) with tumor DNA detection can better predict how head and neck cancer responds to chemoradiotherapy. Researchers will enroll 152 people with advanced oropharyngeal or oral cavity cancer. The goal is to improve per…
Matched conditions: SQUAMOUS CELL CANCER OF HEAD AND NECK (SCCHN)
Phase: NA • Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated May 18, 2026 12:02 UTC